Barcelona, Spain
Joined April 2022
Esta semana hemos sabido que el primer estudio #IMMUNOMICSVHIO, codirigido por Rodrigo Toledo y Elena Garralda, demuestra que la biopsia líquida ultrasensible puede predecir y monitorizar la respuesta a la inmunoterapia en cánceres avanzados. ➡️ linke.to/IMMUNOMICSVHIO_Cast #CAIMI #UITM
3
9
583
I also had the rare (and fun) opportunity to tell an author their work was going to be on the cover of an upcoming issue when I met @RToledoLab at #AACR25! 😊
The May issue of @CD_AACR is now online! The cover features work by Carlota Arenillas, @RToledoLab, et al. providing evidence of convergent genetic adaptation in hypoxic tumors and in high-altitude populations. Read this and much more here: aacrjournals.org/cancerdisco… @VHIO
1
11
1,072
ToledoLab_VHIO retweeted
Featured on the cover: Convergent Genetic Adaptation in Human Tumors Developed Under Systemic Hypoxia and in Populations Living at High Altitudes brnw.ch/21wSxEo By Carlota Arenillas, @RToledoLab, and colleagues @VHIO
4
26
1,980
New paper from our Lab out in @CD_AACR Cancer Discovery ! aacrjournals.org/cancerdisco…
1
4
706
Now online in @CD_AACR: Convergent Genetic Adaptation in Human Tumors Developed Under Systemic Hypoxia and in Populations Living at High Altitudes - by Carlota Arenillas, @RToledoLab, and colleagues doi.org/10.1158/2159-8290.CD… @VHIO
6
19
3,204
It’s a great honor to be part of the @Ensat Network 💪
4
391
What great #ENSAT2023 meeting in Dubrovnik ! Collaborative Network to fight #raretumors
This year amazing @goharmonisation #ENSAT2023 meeting has come to an end. Thank you🙏 @DarkoKastelan and the entire local organising committee for great three days of science and networking in a beautiful location 👏 See you all next year in Palma de Maiorca 😊
2
10
1,948
ToledoLab_VHIO retweeted
Predictive Impact of mRNF43 in MSS mBRAFV600E mCRC Treated With Target Therapy or CTx @JCOPO_ASCO doi.org/10.1200/PO.23.00255 👉pMMR/MSS mBRAFV600E mCRC benefit from TT vs CT independently of RNF43 mutational 👉Nevertheless, intersting efficacy in mRNF43 pts... @myESMO @OncoAlert
11
31
3,285
Enhorabuena‼️ @RToledoLab recibe una de las Ayudas para la Investigación de la @APheipas para investigar la utilidad de la biopsia líquida en un grupo de tumores raros.  ➕ bit.ly/RToledoPHEiPAS-VHIO
4
13
843
Published in @GenomeMedicine, a study co-led by VHIO’s Rodrigo A. Toledo reports on the development of new liquid biopsy methodology that showed 30% increased sensitivity in detecting ctDNA in pts with #AdvancedPancreaticCancer. ➕ bit.ly/ACT-DiscoverVHIO
1
9
30
2,714
Fantastic work by @adameykolab on characterizing embryological development of chromaffin cells using #scRNAseq @ece2023 @ENSAT_news ⁩
NSA on single cell RNAseq just started in Eyup auditorium #ECE2023 !! Come and hear the top quality research of ⁦@adameykolab⁩
1
267
🚨The Vall d’Hebron Institute of #Oncology @VHIO has an #openposition for a Junior Group Leader keen to launch a #research lab in #hematooncology & #Immunotherapy Check here and reach out if you have questions! 👉🏽vhio.net/2023/05/12/ref-48-2… #CARTcell #Immunology #CancerResearch
23
3
39
14,850
Heading to the #ECE2023 ! I invite you to my talk on Liquid biopsy in #raretumors as an opportunity to develop #precisiononcology !
2
180
Glad to share our new publication on PDAC evolution using ACT-Discover @RToledoLab, @DrMhidalgo, and @NickyMcGranahan @VHIO
🗞️Recently published at @GenomeMedicine a study co-led by Rodrigo Toledo, @DrMhidalgo and @NickyMcGranahan reports the development of a new liquid biopsy approach: ACT-discover and shows it is 30% more sensitive than current methods in pancreatic cancer ➕bit.ly/RToledoGenomicsM-VHIO
1
8
1,114
ToledoLab_VHIO retweeted
📢Hoy, el Dr. @EnriquedeAlava, coordinador del proyecto #Immune4ALL nos cuenta cuál es el objetivo principal del proyecto y qué resultados en salud se pretenden alcanzar. 🎯 @CIBER_ISCIII @CIBERONC @CIBERehd @CIBERER @CIBERBBN
19
1
34
3,409
ToledoLab_VHIO retweeted
🔔Today is THE DAY! Kick-off meeting del proyecto con sesión inaugural a cargo del IP de proyecto @EnriquedeAlava.
1
7
10
1,354
🗞 Publicados en @NatureMedicine los resultados de un estudio liderado por @elena_elez y Rodrigo A. Toledo que identifican un biomarcador de respuesta al tratamiento para el #cáncercolorrectal metastásico BRAF-V600E ➕ bit.ly/VHIO-BRAFV600E-Cast
2
6
2
45